After more than 15 years’ experience in the Asian Pacific region, MMI are delighted to announce the opening of MMI, Ltd. in Hong Kong, China. This is the next milestone in the MMI expansion programme. Together with the other MMI offices in Germany, Switzerland & the USA and an established distribution network in more than 70 countries worldwide MMI are now in a strong global position to dominate in the field of single cell isolation and laser microdissection for all biomedical applications.

Prof. Dr. Stefan Seeger, founder and Chairman of the Board of Directors at MMI, says: “The setup of MMI’s new office in Hong Kong is in direct response to our success and rapidly growing business in Asia over the last years. It also follows the dynamic shift in the biomedical research market in this region.” Prof. Dr. Seeger adds that the new base will allow to enhance business relationships to local and regional customers, resulting to facilitate more efficient support and faster service response times. It will increase biotechnology collaborations across the region. The office will also serve as a distribution base for MMI’s high quality products throughout Asia.

Hong Kong is a vibrant city attractive to biomedical companies who are seeking to grow their business. Simon Tsang, Head of Innovation Technology from InvestHK, the government organisation that promotes foreign direct investment, knows this well. “Hong Kong is one of the best locations from which to service all your markets in Asia”, he says. “It is centrally located, easily accessible, and has highly developed research universities, a sophisticated healthcare system, and direct access to the fastest growing pharmaceutical market in the world in Mainland China.”